Nxera Pharma Co Eulerpool Novinky

Nxera Pharma Co Eulerpool News

Nxera Pharma Co Novinky o akciích

Nxera Pharma Co je sledován mnoha novináři a investory po celém světě. Nejaktuálnější Nxera Pharma Co zprávy shromažďujeme zde.

• 13. září ·

  Yahoo
  Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
• 11. září ·

  Yahoo
  Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
• 2. září ·

  Yahoo
  Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 28. srpna ·

  Yahoo
  Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 9. srpna ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024
• 9. července ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• 9. července ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• 27. června ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• 18. června ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• 30. května ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals